Real-world study of tezepelumab for chronic nasal polyps
Part of Ear, nose & throat clinical trials.
This study follows patients with chronic rhinosinusitis with nasal polyps (CRSwNP)—a condition causing blocked sinuses and nasal growths—who are starting a new biologic medication called tezepelumab. Researchers will track how symptoms and quality of life improve over time in everyday medical practice.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years of age or older
- Diagnosed with nasal polyps (CRSwNP) for at least 12 months
- Been on nasal steroid sprays for at least 30 days
- Your doctor believes tezepelumab is appropriate for you
- Able to complete surveys via phone app or paper throughout the study
- Not in another clinical trial or study that could interfere with results
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks how well tezepelumab works for people with chronic sinusitis and nasal polyps in real-world settings. It aims to see if this medication reduces symptoms and the need for surgery.
This trial tests if Tezepelumab improves lung and sinus barrier function in people with severe asthma. It includes those who also have chronic sinusitis with nasal polyps, to see if the drug helps both conditions.
This study follows people with chronic rhinosinusitis and nasal polyps who are starting a biologic medication (omalizumab, mepolizumab, or dupilumab) to see how well it works in real life.
This study watches how well tezepelumab (Tezspire) works in real life for people who are already taking it for approved reasons. It collects information to make sure the medicine is safe and effective outside of a clinical trial.
This trial tests an injectable drug called TQC2731 for people with chronic sinusitis and nasal polyps that haven't been controlled well enough by standard treatments like steroid sprays or surgery. The goal is to see if it helps reduce nasal congestion, improve sense of smell, and shrink polyps.
This trial tests an investigational medication called AK139 for people with chronic sinusitis and nasal polyps. The treatment aims to reduce nasal congestion and polyp size, potentially improving symptoms.
Hear when a new Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.